Multiple Sclerosis Therapy for Pediatric Patients Approved by FDA
May 12th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Read More
President Trump Urges More Competition to Lower Drug Costs
May 12th 2018The President also noted he has directed officials to take actions to end what he termed "global freeloading," which he explained as lowered prices on drugs in other countries compared with the United States, where much of the investment funds for medical research originate.
Read More
Lofexidine Reduces Opioid Withdrawal Symptoms in Phase 3 Studies
May 11th 2018Lofexidine (LUCEMYRA) safely reduces opioid withdrawal symptoms at 3.2 mg/day and 2.4 mg/day to a clinically meaningful extent, facilitating opioid discontinuation treatment, according to data from a pooled analysis.
Read More
Case Study: CAR T Therapy Has Early Success as Acute Myeloid Leukemia Treatment
May 10th 2018According to the case study, an acute myeloid leukemia patient has remained cancer free for 9 months following treatment with the chimeric antigen receptor (CAR) T-cell treatment, CYAD-01, and a bone marrow transplant.
Read More